Retinal nerve fiber layer thickness and visual hallucinations in Parkinson's Disease
ABSTRACT Defective visual information processing from both central and peripheral pathways is one of the suggested mechanisms of visual hallucination in Parkinson's disease (PD). To investigate the role of retinal thinning for visual hallucination in PD, we conducted a case‐control study using...
Saved in:
Published in | Movement disorders Vol. 29; no. 1; pp. 61 - 67 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Blackwell Publishing Ltd
01.01.2014
Wiley Subscription Services, Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | ABSTRACT
Defective visual information processing from both central and peripheral pathways is one of the suggested mechanisms of visual hallucination in Parkinson's disease (PD). To investigate the role of retinal thinning for visual hallucination in PD, we conducted a case‐control study using spectral domain optical coherence tomography. We examined a representative sample of 61 patients with PD and 30 healthy controls who had no history of ophthalmic diseases. General ophthalmologic examinations and optical coherence tomography scans were performed in each participant. Total macular thickness and the thickness of each retinal layer on horizontal scans through the fovea were compared between the groups. In a comparison between patients with PD and healthy controls, there was significant parafoveal inner nuclear layer thinning, whereas other retinal layers, including the retinal nerve fiber layer, as well as total macular thicknesses were not different. In terms of visual hallucinations among the PD subgroups, only retinal nerve fiber layer thickness differed significantly, whereas total macular thickness and the thickness of other retinal layers did not differ. The retinal nerve fiber layer was thinnest in the group that had hallucinations without dementia, followed by the group that had hallucinations with dementia, and the group that had no hallucinations and no dementia. General ophthalmologic examinations did not reveal any significant correlation with hallucinations. There were no significant correlations between retinal thicknesses and duration or severity of PD and medication dosages. The results indicate that retinal nerve fiber layer thinning may be related to visual hallucination in nondemented patients with PD. Replication studies as well as further studies to elucidate the mechanism of thinning are warranted. © 2013 International Parkinson and Movement Disorder Society |
---|---|
AbstractList | Defective visual information processing from both central and peripheral pathways is one of the suggested mechanisms of visual hallucination in Parkinson's disease (PD). To investigate the role of retinal thinning for visual hallucination in PD, we conducted a case-control study using spectral domain optical coherence tomography. We examined a representative sample of 61 patients with PD and 30 healthy controls who had no history of ophthalmic diseases. General ophthalmologic examinations and optical coherence tomography scans were performed in each participant. Total macular thickness and the thickness of each retinal layer on horizontal scans through the fovea were compared between the groups. In a comparison between patients with PD and healthy controls, there was significant parafoveal inner nuclear layer thinning, whereas other retinal layers, including the retinal nerve fiber layer, as well as total macular thicknesses were not different. In terms of visual hallucinations among the PD subgroups, only retinal nerve fiber layer thickness differed significantly, whereas total macular thickness and the thickness of other retinal layers did not differ. The retinal nerve fiber layer was thinnest in the group that had hallucinations without dementia, followed by the group that had hallucinations with dementia, and the group that had no hallucinations and no dementia. General ophthalmologic examinations did not reveal any significant correlation with hallucinations. There were no significant correlations between retinal thicknesses and duration or severity of PD and medication dosages. The results indicate that retinal nerve fiber layer thinning may be related to visual hallucination in nondemented patients with PD. Replication studies as well as further studies to elucidate the mechanism of thinning are warranted. ABSTRACT Defective visual information processing from both central and peripheral pathways is one of the suggested mechanisms of visual hallucination in Parkinson's disease (PD). To investigate the role of retinal thinning for visual hallucination in PD, we conducted a case‐control study using spectral domain optical coherence tomography. We examined a representative sample of 61 patients with PD and 30 healthy controls who had no history of ophthalmic diseases. General ophthalmologic examinations and optical coherence tomography scans were performed in each participant. Total macular thickness and the thickness of each retinal layer on horizontal scans through the fovea were compared between the groups. In a comparison between patients with PD and healthy controls, there was significant parafoveal inner nuclear layer thinning, whereas other retinal layers, including the retinal nerve fiber layer, as well as total macular thicknesses were not different. In terms of visual hallucinations among the PD subgroups, only retinal nerve fiber layer thickness differed significantly, whereas total macular thickness and the thickness of other retinal layers did not differ. The retinal nerve fiber layer was thinnest in the group that had hallucinations without dementia, followed by the group that had hallucinations with dementia, and the group that had no hallucinations and no dementia. General ophthalmologic examinations did not reveal any significant correlation with hallucinations. There were no significant correlations between retinal thicknesses and duration or severity of PD and medication dosages. The results indicate that retinal nerve fiber layer thinning may be related to visual hallucination in nondemented patients with PD. Replication studies as well as further studies to elucidate the mechanism of thinning are warranted. © 2013 International Parkinson and Movement Disorder Society Defective visual information processing from both central and peripheral pathways is one of the suggested mechanisms of visual hallucination in Parkinson's disease (PD). To investigate the role of retinal thinning for visual hallucination in PD, we conducted a case-control study using spectral domain optical coherence tomography. We examined a representative sample of 61 patients with PD and 30 healthy controls who had no history of ophthalmic diseases. General ophthalmologic examinations and optical coherence tomography scans were performed in each participant. Total macular thickness and the thickness of each retinal layer on horizontal scans through the fovea were compared between the groups. In a comparison between patients with PD and healthy controls, there was significant parafoveal inner nuclear layer thinning, whereas other retinal layers, including the retinal nerve fiber layer, as well as total macular thicknesses were not different. In terms of visual hallucinations among the PD subgroups, only retinal nerve fiber layer thickness differed significantly, whereas total macular thickness and the thickness of other retinal layers did not differ. The retinal nerve fiber layer was thinnest in the group that had hallucinations without dementia, followed by the group that had hallucinations with dementia, and the group that had no hallucinations and no dementia. General ophthalmologic examinations did not reveal any significant correlation with hallucinations. There were no significant correlations between retinal thicknesses and duration or severity of PD and medication dosages. The results indicate that retinal nerve fiber layer thinning may be related to visual hallucination in nondemented patients with PD. Replication studies as well as further studies to elucidate the mechanism of thinning are warranted. © 2013 International Parkinson and Movement Disorder Society [PUBLICATION ABSTRACT] |
Author | Lee, Jee-Young Ahn, Jeeyun Kim, Jae Min Jeon, Beom S. Kim, Tae Wan Kim, Han-Joon |
Author_xml | – sequence: 1 givenname: Jee-Young surname: Lee fullname: Lee, Jee-Young email: twkim93@medimail.co.kr organization: Department of Neurology, Seoul National University-Seoul Metropolitan Government Boramae Medical Center, Seoul, Republic of Korea – sequence: 2 givenname: Jae Min surname: Kim fullname: Kim, Jae Min organization: Department of Ophthalmology, Seoul National University College of Medicine, Seoul, Korea, Seoul, Republic of Korea – sequence: 3 givenname: Jeeyun surname: Ahn fullname: Ahn, Jeeyun organization: Department of Ophthalmology, Seoul National University College of Medicine, Seoul, Korea, Seoul, Republic of Korea – sequence: 4 givenname: Han-Joon surname: Kim fullname: Kim, Han-Joon organization: Department of Neurology, Seoul National University College of Medicine, Seoul, Republic of Korea – sequence: 5 givenname: Beom S. surname: Jeon fullname: Jeon, Beom S. organization: Department of Neurology, Seoul National University College of Medicine, Seoul, Republic of Korea – sequence: 6 givenname: Tae Wan surname: Kim fullname: Kim, Tae Wan email: twkim93@medimail.co.kr organization: Department of Ophthalmology, Seoul National University College of Medicine, Seoul, Korea, Seoul, Republic of Korea |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/23775932$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kE1P1UAUhicGIxd04R8wTVwoi8Kc-ehMlwYUTACJYnA3mbanYaB3inNa9P57Bi6wMHFzzuZ53-R9tthGHCMy9hb4LnAu9pYd7QqtlXzBFqAllFZos8EW3FpdSrB6k20RXXEOoKF6xTaFNEbXUizY-XecQvRDETHdYtGHBlMx-FW-02VoryMSFT52xW2gOWOXfhjmNiemMEYqQizOfLoOkcb4gYqDQOgJX7OXvR8I3zz-bfbzy-fz_aPy-Nvh1_1Px2WrtJFlr6wGUynV-QpRyVZxsDWvWlE1XQNSNNDXPRolrNS8bSojVVND3faKGw0gt9nHde9NGn_PSJNbBmpxGHzEcSYHqhYmjwab0ff_oFfjnPLwBwp4nbt5pnbWVJtGooS9u0lh6dPKAXf3ql1W7R5UZ_bdY-PcLLF7Jp_cZmBvDfwJA67-3-RODn48VZbrRKAJ_z4nsmCXtxvtLk4PnbjglbXizP2Sd6Smlv0 |
CODEN | MOVDEA |
CitedBy_id | crossref_primary_10_1016_j_parkreldis_2024_106065 crossref_primary_10_1016_j_neuropsychologia_2017_03_002 crossref_primary_10_1186_s41983_021_00421_1 crossref_primary_10_1080_01658107_2020_1835994 crossref_primary_10_1007_s00415_020_09925_x crossref_primary_10_1016_j_jns_2019_06_009 crossref_primary_10_1002_ana_24182 crossref_primary_10_3390_biom13020218 crossref_primary_10_1155_2023_7739944 crossref_primary_10_1016_j_pharmthera_2017_02_009 crossref_primary_10_1016_j_survophthal_2021_06_001 crossref_primary_10_1186_s12883_023_03373_6 crossref_primary_10_1016_j_parkreldis_2018_06_016 crossref_primary_10_1016_j_psychres_2021_113780 crossref_primary_10_1007_s10072_020_04289_6 crossref_primary_10_1016_j_jns_2015_05_007 crossref_primary_10_3389_fnins_2017_00045 crossref_primary_10_1038_s41598_022_21847_4 crossref_primary_10_1038_nrneurol_2016_200 crossref_primary_10_3233_JPD_150686 crossref_primary_10_1007_s11910_017_0725_2 crossref_primary_10_1002_mds_26533 crossref_primary_10_1016_j_trci_2019_09_006 crossref_primary_10_1590_0004_282x_anp_2021_0134 crossref_primary_10_1098_rspb_2014_2047 crossref_primary_10_1007_s00401_018_01956_z crossref_primary_10_1111_ene_14613 crossref_primary_10_1212_WNL_0000000000006157 crossref_primary_10_3346_jkms_2023_38_e86 crossref_primary_10_1038_s41531_022_00325_8 crossref_primary_10_1167_iovs_17_23230 crossref_primary_10_1177_1756285616664300 crossref_primary_10_4103_AOMD_AOMD_35_20 crossref_primary_10_1038_s41598_020_77833_1 crossref_primary_10_3389_fnimg_2024_1340754 crossref_primary_10_3389_fneur_2020_579113 crossref_primary_10_1093_brain_aww175 crossref_primary_10_1093_schbul_sbad121 crossref_primary_10_3389_fnins_2021_726476 crossref_primary_10_1007_s13760_019_01228_x crossref_primary_10_3389_fneur_2017_00206 crossref_primary_10_1016_j_jns_2017_06_011 crossref_primary_10_1038_s41582_022_00618_9 crossref_primary_10_1002_mds_27454 crossref_primary_10_1016_j_schres_2019_06_019 crossref_primary_10_1016_j_parkreldis_2019_04_023 crossref_primary_10_3389_fpsyt_2021_684720 crossref_primary_10_1007_s40265_016_0600_5 crossref_primary_10_1007_s40267_016_0362_x crossref_primary_10_1002_mds_26360 crossref_primary_10_1016_j_schres_2019_07_007 crossref_primary_10_1007_s00415_022_11427_x crossref_primary_10_1002_brb3_1611 crossref_primary_10_1016_j_psiq_2021_100347 crossref_primary_10_1007_s00415_020_10304_9 crossref_primary_10_3389_fnins_2020_567129 crossref_primary_10_1007_s00115_021_01165_2 crossref_primary_10_1007_s10072_020_04266_z crossref_primary_10_1134_S0362119717080072 crossref_primary_10_1097_MD_0000000000035354 crossref_primary_10_1136_jnnp_2019_322702 crossref_primary_10_1007_s00415_016_8230_0 crossref_primary_10_1002_mds_25741 crossref_primary_10_1111_eip_13103 crossref_primary_10_1007_s00415_019_09430_w crossref_primary_10_1016_j_bionps_2020_100018 crossref_primary_10_17116_jnevro2018118062105 crossref_primary_10_2174_1381612828666220428102802 crossref_primary_10_3389_fnins_2021_799526 crossref_primary_10_1007_s11682_019_00185_6 crossref_primary_10_1016_j_preteyeres_2020_100938 crossref_primary_10_1159_000448517 crossref_primary_10_3389_fnins_2020_00025 crossref_primary_10_1016_j_cortex_2021_11_001 crossref_primary_10_1002_mds_25896 crossref_primary_10_1177_0891988719892318 crossref_primary_10_1007_s10072_018_3244_2 crossref_primary_10_1136_jnnp_2022_329342 crossref_primary_10_1002_jmri_29387 crossref_primary_10_1016_j_scog_2015_03_004 crossref_primary_10_1007_s00702_023_02724_4 crossref_primary_10_3390_brainsci13081173 crossref_primary_10_1155_2018_4163239 crossref_primary_10_1016_j_oret_2021_03_006 crossref_primary_10_1016_j_pdpdt_2022_103213 crossref_primary_10_1155_2024_8555083 crossref_primary_10_1155_2015_709191 crossref_primary_10_1002_cne_25481 crossref_primary_10_5498_wjp_v11_i8_491 |
Cites_doi | 10.1016/j.parkreldis.2011.03.004 10.1007/s00702-012-0909-5 10.1001/archneur.64.7.984 10.1002/mds.21956 10.1371/journal.pone.0034891 10.1016/j.ophtha.2012.05.003 10.5301/EJO.2010.1318 10.1002/mds.23891 10.1002/mds.22340 10.1007/s10633-007-9091-8 10.1001/archophthalmol.2009.106 10.1111/j.1468-1331.2007.01768.x 10.1002/mds.20263 10.1586/14737175.7.12.1731 10.1016/0006-8993(90)91056-M 10.1016/j.ophtha.2006.08.046 10.1016/j.parkreldis.2012.07.012 10.1016/j.jns.2006.05.025 10.1167/iovs.06-0942 10.1016/j.visres.2004.06.009 10.1212/01.WNL.0000141853.27081.BD 10.1002/gps.1965 10.1093/brain/123.4.733 10.1136/jnnp.55.3.181 10.1093/brain/awp001 10.1002/mds.20308 10.1093/brain/awr225 10.1007/s00415-005-0840-x 10.1038/eye.2008.363 10.1002/mds.22678 10.1002/cne.902100108 10.1212/WNL.0b013e31827deb74 10.1002/mds.21507 10.1016/j.ajo.2008.06.010 |
ContentType | Journal Article |
Copyright | Copyright © 2013 Movement Disorder Society Copyright © 2013 Movement Disorder Society. |
Copyright_xml | – notice: Copyright © 2013 Movement Disorder Society – notice: Copyright © 2013 Movement Disorder Society. |
DBID | BSCLL CGR CUY CVF ECM EIF NPM AAYXX CITATION 7TK 8FD FR3 K9. NAPCQ P64 RC3 7X8 |
DOI | 10.1002/mds.25543 |
DatabaseName | Istex Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Neurosciences Abstracts Technology Research Database Engineering Research Database ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium Biotechnology and BioEngineering Abstracts Genetics Abstracts MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Nursing & Allied Health Premium Genetics Abstracts Technology Research Database ProQuest Health & Medical Complete (Alumni) Engineering Research Database Neurosciences Abstracts Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic Nursing & Allied Health Premium CrossRef |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1531-8257 |
EndPage | 67 |
ExternalDocumentID | 3188398461 10_1002_mds_25543 23775932 MDS25543 ark_67375_WNG_2W06882P_X |
Genre | article Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- .3N .GA .GJ .Y3 05W 0R~ 10A 123 1CY 1L6 1OB 1OC 1ZS 31~ 33P 3PY 3SF 3WU 4.4 4ZD 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5VS 66C 6PF 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AANLZ AAONW AASGY AAVGM AAWTL AAXRX AAZKR ABCQN ABCUV ABEML ABHUG ABIJN ABJNI ABLJU ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACGOF ACMXC ACPOU ACPRK ACSCC ACXBN ACXME ACXQS ADAWD ADBBV ADBTR ADDAD ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFFPM AFGKR AFPWT AFVGU AFZJQ AGJLS AHBTC AHMBA AIACR AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BSCLL BY8 C45 CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR1 DR2 DRFUL DRMAN DRSTM DU5 EBD EBS EJD EMOBN F00 F01 F04 F5P FEDTE FUBAC FYBCS G-S G.N GNP GODZA H.X HBH HF~ HHY HHZ HVGLF HZ~ IX1 J0M JPC KBYEO KQQ LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES M6M MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ NNB O66 O9- OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 QRW R.K RIWAO RJQFR ROL RWD RWI RX1 RYL SAMSI SUPJJ SV3 TEORI TWZ UB1 V2E V9Y W8V W99 WBKPD WHWMO WIB WIH WIJ WIK WJL WOHZO WQJ WRC WUP WVDHM WXI WXSBR XG1 XV2 YCJ ZGI ZZTAW ~IA ~WT AITYG HGLYW OIG CGR CUY CVF ECM EIF NPM AAYXX CITATION 7TK 8FD FR3 K9. NAPCQ P64 RC3 7X8 |
ID | FETCH-LOGICAL-c4573-f48517644da6ee43c4018906c26bdb132b1f9fe7428350cb6734b919cf4075113 |
IEDL.DBID | DR2 |
ISSN | 0885-3185 |
IngestDate | Fri Aug 16 09:27:04 EDT 2024 Fri Sep 13 08:15:37 EDT 2024 Fri Aug 23 03:27:33 EDT 2024 Sat Sep 28 08:00:07 EDT 2024 Sat Aug 24 01:04:53 EDT 2024 Wed Jan 17 05:02:52 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | retina thickness Parkinson's disease optical computed tomography visual hallucination |
Language | English |
License | Copyright © 2013 Movement Disorder Society. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4573-f48517644da6ee43c4018906c26bdb132b1f9fe7428350cb6734b919cf4075113 |
Notes | ark:/67375/WNG-2W06882P-X istex:88BB260738B16D5090C104F1EAC6DF3A87844106 ArticleID:MDS25543 This study was supported by a clinical research grant from Seoul National University‐Seoul Metropolitan Government (03‐2011‐13). Full financial disclosures and author roles may be found in the online version of this article. Nothing to report. Relevant conflicts of interest/financial disclosures Funding agencies ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 23775932 |
PQID | 1491097340 |
PQPubID | 1016421 |
PageCount | 7 |
ParticipantIDs | proquest_miscellaneous_1492701118 proquest_journals_1491097340 crossref_primary_10_1002_mds_25543 pubmed_primary_23775932 wiley_primary_10_1002_mds_25543_MDS25543 istex_primary_ark_67375_WNG_2W06882P_X |
PublicationCentury | 2000 |
PublicationDate | January 2014 |
PublicationDateYYYYMMDD | 2014-01-01 |
PublicationDate_xml | – month: 01 year: 2014 text: January 2014 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Hoboken |
PublicationTitle | Movement disorders |
PublicationTitleAlternate | Mov Disord |
PublicationYear | 2014 |
Publisher | Blackwell Publishing Ltd Wiley Subscription Services, Inc |
Publisher_xml | – name: Blackwell Publishing Ltd – name: Wiley Subscription Services, Inc |
References | Abbott EJ, Connor GB, Artes PH, Abado RV. Visual loss and visual hallucinations in patients with age-related macular degeneration (Charles Bonnet syndrome). Investigative Ophthalmol Vis Sci 2007;48:1416-1423. Budenz DL, Anderson DR, Varma R, et al. Determinants of normal retinal nerve fiber layer thickness measured by Stratus OCT. Ophthalmology 2007;114:1046-1052. Papapetropoulos S, Argyriou AA, Ellul J. Factors associated with drug-induced visual hallucinations in Parkinson's disease. J Neurol 2005;252:1223-1228. Bodis-Wollner I. Foveal vision is impaired in Parkinson's disease. Parkinsonism Relat Disord 2013;19:1-14. Boecker H, Ceballos-Baumann AO, Volk D, Conrad B, Forstl H, Haussermann P. Metabolic alterations in patients with Parkinson disease and visual hallucinations. Arch Neurol 2007;64:984-988. Fenelon G, Mahieux F, Huon R, Ziegler M. Hallucinations in Parkinson's disease: prevalence, phenomenology and risk factors. Brain 2000;123:733-745. Harnois C, Di Paolo T. Decreased dopamine in the retinas of patients with Parkinson's disease. Invest Ophthalmol Vis Sci 1990;31:2473-2475. Stebbins GT, Goetz CG, Carrillo MC, et al. Altered cortical visual processing in PD with hallucinations: an fMRI study. Neurology 2004;63:1409-1416. Hajee ME, March WF, Lazzaro DR, et al. Inner retinal layer thinning in Parkinson's disease. Arch Ophthalmol 2009;127:737-741. Jindahra P, Petrie A, Plant GT. Retrograde trans-synaptic retinal ganglion cell loss identified by optical coherence tomography. Brain 2009;132:628-634. Archibald NK, Clarke MP, Mosimann UP, Burn DJ. Retinal thickness in Parkinson's disease. Parkinsonism Relat Disord 2011;17:431-436. Ramirez-Ruiz B, Marti MJ, Tolosa E, et al. Cerebral atrophy in Parkinson's disease patients with visual hallucinations. Eur J Neurol 2007;14:750-756. Goetz CG, Tilley BC, Shaftman SR, et al. Movement Disorder Society UPDRS Revision Task Force. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord 2008;23:2129-2170. Schrier EM, Adam CR, Spund B, Glazman S, Bodis-Wollner I. Interocular asymmetry of foveal thickness in Parkinson's disease [serial online]. J Ophthalmol 2012;728457. Spund B, Ding Y, Liu T, Selesnick I, Glazman S, Shrier EM, Bodis-Wollner I. Remodeling of the fovea in Parkinson disease. J Neural Transm 2013;120:745-753. Verhulst E, Vrijghem JC. Accuracy of intraocular lens power calculations using the Zeiss IOL master. A prospective study. Bull Soc Belge Ophtalmol 2001;281:61-65. Aaker GD, Myung JS, Ehrlich JR, Mohammed M, Henchcliffe C, Kiss S. Detection of retinal changes in Parkinson's disease with spectral-domain optical coherence tomography. Clin Ophthalmol 2010;4:1427-1432. Garcia-Martin E, Satue M, et al. Ability and reproducibility of Fourier-domain optical coherence tomography to detect retinal nerve fiber layer atrophy in Parkinson's disease. Ophthalmology 2012;119:2161-2167. Frederick JM, Rayborn ME, Laties AM, et al. Dopaminergic neurons in the human retina. J Comp Neurol 1982;210:65-79. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992:55:181-184. Tatton WG, Kwan MM, Verrier MC, et al. MPTP produces reversible disappearance of tyrosine hydroxylase-containing retinal amacrine cells. Brain Res 1990;527:21-31. Lee JY, Lee EK, Lim JY, et al. Association of DRD3 and GRIN2B with impulse control and related behaviors in Parkinson's disease. Mov Disord 2009;24:1803-1810. Albrecht P, Muller AK, Sudmeyer M, et al. Optical coherence tomography in parkinsonian syndromes [serial online]. PLoS One 2012;7:e34891. Gallagher DA, Parkkinen L, O'Sullivan SS, et al. Testing an aetiological model of visual hallucinations in Parkinson's disease. Brain 2011;134:3299-3309. Moschos MM, Tagaris G, Markopoulos I, Margetis I, Tsapakis S, Kanakis M, Koutsandrea C. Morphologic changes and functional retinal impairment in patients with Parkinson disease without visual loss. Eur J Ophthalmol 2011;21:24-29. Inzelberg R, Ramirez JA, Nisipeanu P, Ophir A. Retinal nerve fiber layer thinning in Parkinson disease. Vis Res 2004;44:2793-2797. Altintas O, Iseri P, Ozkan B, Caglar Y. Correlation between retinal morphological and functional findings and clinical severity in Parkinson's disease. Doc Ophthalmol 2008;116:137-146. Mosimann UP, Collerton D, Dudley R, et al. A semi-structured interview to assess visual hallucinations in older people. Int J Geriatr Psychiatry 2008;23:712-718. Bagci AM, Shahidi M, Ansari R, et al. Thickness profiles of retinal layers by optical coherence tomography image segmentation. Am J Ophthalmol 2008;146:679-687. deMaindreville AD, Fenelon G, Mahieux F. Hallucinations in Parkinson's disease: a follow-up study. Mov Disord 2005;20:212-217. Emre M, Aarsland D, Brown R, et al. Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov Disord 2007;22:1689-1707. Diederich NJ, Goetz CG, Stebbins GT. Repeated visual hallucinations in Parkinson's disease as disturbed external/internal perception: focused review and a new integrative model. Mov Disord 2005;20:130-140. Onofrj M, Bonanni L, Albani G, et al. Visual hallucinations in Parkinson's disease: clues to separate origins. J Neurol Sci 2006;248:143-150. Hely MA, Reid WG, Adena MA, et al. The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years. Mov Disord 2008;23:837-844. Archibald NK, Clarke MP, Mosimann UP, Burn DJ. Visual symptoms in Parkinson's disease and Parkinson's disease dementia. Mov Disord 2011;26:2387-2395. Khoo TK, Yarnall AJ, Duncan GW, et al. The spectrum of nonmotor symptoms in early Parkinson disease. Neurology 2013;80:276-281. Forte R, Cennamo GL, Finelli ML, de Crecchio G. Comparison of time domain Stratus OCT and spectral domain SLO/OCT for assessment of macular thickness and volume. Eye (Lond) 2009;23:2071-2078. Onofrj M, Thomas A, Bonanni L. New approaches to understanding hallucinations in Parkinson's disease: phenomenology and possible origins. Expert Rev Neurother 2007;7:1731-1750. 1990; 527 2009; 23 2004; 44 1990; 31 2004; 63 2009; 24 2005; 252 2012 2001; 281 2009; 132 2005; 20 2013; 120 2008; 146 2011; 17 1992; 55 2011; 134 2007; 14 2007; 114 2013; 19 2013; 80 1982; 210 2008; 23 2011; 21 2007; 7 2008; 116 2011; 26 2000; 123 2006; 248 2007; 64 2012; 7 2007; 22 2010; 4 2012; 119 2009; 127 2007; 48 e_1_2_5_28_1 e_1_2_5_25_1 e_1_2_5_26_1 Verhulst E (e_1_2_5_27_1) 2001; 281 e_1_2_5_23_1 e_1_2_5_24_1 e_1_2_5_21_1 e_1_2_5_22_1 e_1_2_5_29_1 Harnois C (e_1_2_5_12_1) 1990; 31 Schrier EM (e_1_2_5_11_1) 2012 e_1_2_5_20_1 e_1_2_5_15_1 e_1_2_5_38_1 e_1_2_5_14_1 e_1_2_5_39_1 e_1_2_5_17_1 e_1_2_5_36_1 e_1_2_5_9_1 e_1_2_5_16_1 e_1_2_5_37_1 e_1_2_5_8_1 e_1_2_5_34_1 e_1_2_5_7_1 e_1_2_5_10_1 e_1_2_5_35_1 e_1_2_5_6_1 e_1_2_5_13_1 e_1_2_5_32_1 e_1_2_5_5_1 e_1_2_5_33_1 e_1_2_5_4_1 e_1_2_5_3_1 e_1_2_5_2_1 e_1_2_5_19_1 Aaker GD (e_1_2_5_18_1) 2010; 4 e_1_2_5_30_1 e_1_2_5_31_1 |
References_xml | – volume: 31 start-page: 2473 year: 1990 end-page: 2475 article-title: Decreased dopamine in the retinas of patients with Parkinson's disease publication-title: Invest Ophthalmol Vis Sci – volume: 21 start-page: 24 year: 2011 end-page: 29 article-title: Morphologic changes and functional retinal impairment in patients with Parkinson disease without visual loss publication-title: Eur J Ophthalmol – volume: 146 start-page: 679 year: 2008 end-page: 687 article-title: Thickness profiles of retinal layers by optical coherence tomography image segmentation publication-title: Am J Ophthalmol – volume: 23 start-page: 712 year: 2008 end-page: 718 article-title: A semi‐structured interview to assess visual hallucinations in older people publication-title: Int J Geriatr Psychiatry – volume: 64 start-page: 984 year: 2007 end-page: 988 article-title: Metabolic alterations in patients with Parkinson disease and visual hallucinations publication-title: Arch Neurol – volume: 14 start-page: 750 year: 2007 end-page: 756 article-title: Cerebral atrophy in Parkinson's disease patients with visual hallucinations publication-title: Eur J Neurol – volume: 24 start-page: 1803 year: 2009 end-page: 1810 article-title: Association of DRD3 and GRIN2B with impulse control and related behaviors in Parkinson's disease publication-title: Mov Disord – volume: 80 start-page: 276 year: 2013 end-page: 281 article-title: The spectrum of nonmotor symptoms in early Parkinson disease publication-title: Neurology – volume: 48 start-page: 1416 year: 2007 end-page: 1423 article-title: Visual loss and visual hallucinations in patients with age‐related macular degeneration (Charles Bonnet syndrome) publication-title: Investigative Ophthalmol Vis Sci – volume: 116 start-page: 137 year: 2008 end-page: 146 article-title: Correlation between retinal morphological and functional findings and clinical severity in Parkinson's disease publication-title: Doc Ophthalmol – volume: 119 start-page: 2161 year: 2012 end-page: 2167 article-title: Ability and reproducibility of Fourier‐domain optical coherence tomography to detect retinal nerve fiber layer atrophy in Parkinson's disease publication-title: Ophthalmology – volume: 527 start-page: 21 year: 1990 end-page: 31 article-title: MPTP produces reversible disappearance of tyrosine hydroxylase‐containing retinal amacrine cells publication-title: Brain Res – volume: 63 start-page: 1409 year: 2004 end-page: 1416 article-title: Altered cortical visual processing in PD with hallucinations: an fMRI study publication-title: Neurology – volume: 210 start-page: 65 year: 1982 end-page: 79 article-title: Dopaminergic neurons in the human retina publication-title: J Comp Neurol – volume: 114 start-page: 1046 year: 2007 end-page: 1052 article-title: Determinants of normal retinal nerve fiber layer thickness measured by Stratus OCT publication-title: Ophthalmology – volume: 55 start-page: 181 year: 1992 end-page: 184 article-title: Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico‐pathological study of 100 cases publication-title: J Neurol Neurosurg Psychiatry – volume: 23 start-page: 837 year: 2008 end-page: 844 article-title: The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years publication-title: Mov Disord – volume: 23 start-page: 2129 year: 2008 end-page: 2170 article-title: Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): scale presentation and clinimetric testing results publication-title: Mov Disord – volume: 281 start-page: 61 year: 2001 end-page: 65 article-title: Accuracy of intraocular lens power calculations using the Zeiss IOL master. A prospective study publication-title: Bull Soc Belge Ophtalmol – volume: 20 start-page: 130 year: 2005 end-page: 140 article-title: Repeated visual hallucinations in Parkinson's disease as disturbed external/internal perception: focused review and a new integrative model publication-title: Mov Disord – volume: 22 start-page: 1689 year: 2007 end-page: 1707 article-title: Clinical diagnostic criteria for dementia associated with Parkinson's disease publication-title: Mov Disord – volume: 17 start-page: 431 year: 2011 end-page: 436 article-title: Retinal thickness in Parkinson's disease publication-title: Parkinsonism Relat Disord – volume: 248 start-page: 143 year: 2006 end-page: 150 article-title: Visual hallucinations in Parkinson's disease: clues to separate origins publication-title: J Neurol Sci – volume: 4 start-page: 1427 year: 2010 end-page: 1432 article-title: Detection of retinal changes in Parkinson's disease with spectral‐domain optical coherence tomography publication-title: Clin Ophthalmol – volume: 120 start-page: 745 year: 2013 end-page: 753 article-title: Remodeling of the fovea in Parkinson disease publication-title: J Neural Transm – volume: 7 start-page: 1731 year: 2007 end-page: 1750 article-title: New approaches to understanding hallucinations in Parkinson's disease: phenomenology and possible origins publication-title: Expert Rev Neurother – volume: 7 start-page: e34891 year: 2012 article-title: Optical coherence tomography in parkinsonian syndromes [serial online] publication-title: PLoS One – volume: 252 start-page: 1223 year: 2005 end-page: 1228 article-title: Factors associated with drug‐induced visual hallucinations in Parkinson's disease publication-title: J Neurol – volume: 127 start-page: 737 year: 2009 end-page: 741 article-title: Inner retinal layer thinning in Parkinson's disease publication-title: Arch Ophthalmol – volume: 23 start-page: 2071 year: 2009 end-page: 2078 article-title: Comparison of time domain Stratus OCT and spectral domain SLO/OCT for assessment of macular thickness and volume publication-title: Eye (Lond) – volume: 19 start-page: 1 year: 2013 end-page: 14 article-title: Foveal vision is impaired in Parkinson's disease publication-title: Parkinsonism Relat Disord – start-page: 728457 year: 2012 article-title: Interocular asymmetry of foveal thickness in Parkinson's disease [serial online] publication-title: J Ophthalmol – volume: 134 start-page: 3299 year: 2011 end-page: 3309 article-title: Testing an aetiological model of visual hallucinations in Parkinson's disease publication-title: Brain – volume: 44 start-page: 2793 year: 2004 end-page: 2797 article-title: Retinal nerve fiber layer thinning in Parkinson disease publication-title: Vis Res – volume: 20 start-page: 212 year: 2005 end-page: 217 article-title: Hallucinations in Parkinson's disease: a follow‐up study publication-title: Mov Disord – volume: 26 start-page: 2387 year: 2011 end-page: 2395 article-title: Visual symptoms in Parkinson's disease and Parkinson's disease dementia publication-title: Mov Disord – volume: 123 start-page: 733 year: 2000 end-page: 745 article-title: Hallucinations in Parkinson's disease: prevalence, phenomenology and risk factors publication-title: Brain – volume: 132 start-page: 628 year: 2009 end-page: 634 article-title: Retrograde trans‐synaptic retinal ganglion cell loss identified by optical coherence tomography publication-title: Brain – ident: e_1_2_5_17_1 doi: 10.1016/j.parkreldis.2011.03.004 – ident: e_1_2_5_20_1 doi: 10.1007/s00702-012-0909-5 – ident: e_1_2_5_38_1 doi: 10.1001/archneur.64.7.984 – ident: e_1_2_5_6_1 doi: 10.1002/mds.21956 – ident: e_1_2_5_19_1 doi: 10.1371/journal.pone.0034891 – ident: e_1_2_5_21_1 doi: 10.1016/j.ophtha.2012.05.003 – ident: e_1_2_5_22_1 doi: 10.5301/EJO.2010.1318 – ident: e_1_2_5_2_1 doi: 10.1002/mds.23891 – ident: e_1_2_5_26_1 doi: 10.1002/mds.22340 – ident: e_1_2_5_14_1 doi: 10.1007/s10633-007-9091-8 – ident: e_1_2_5_15_1 doi: 10.1001/archophthalmol.2009.106 – ident: e_1_2_5_37_1 doi: 10.1111/j.1468-1331.2007.01768.x – ident: e_1_2_5_9_1 doi: 10.1002/mds.20263 – ident: e_1_2_5_34_1 doi: 10.1586/14737175.7.12.1731 – volume: 4 start-page: 1427 year: 2010 ident: e_1_2_5_18_1 article-title: Detection of retinal changes in Parkinson's disease with spectral‐domain optical coherence tomography publication-title: Clin Ophthalmol contributor: fullname: Aaker GD – ident: e_1_2_5_13_1 doi: 10.1016/0006-8993(90)91056-M – ident: e_1_2_5_30_1 doi: 10.1016/j.ophtha.2006.08.046 – ident: e_1_2_5_39_1 doi: 10.1016/j.parkreldis.2012.07.012 – ident: e_1_2_5_7_1 doi: 10.1016/j.jns.2006.05.025 – ident: e_1_2_5_36_1 doi: 10.1167/iovs.06-0942 – ident: e_1_2_5_16_1 doi: 10.1016/j.visres.2004.06.009 – ident: e_1_2_5_35_1 doi: 10.1212/01.WNL.0000141853.27081.BD – ident: e_1_2_5_25_1 doi: 10.1002/gps.1965 – volume: 281 start-page: 61 year: 2001 ident: e_1_2_5_27_1 article-title: Accuracy of intraocular lens power calculations using the Zeiss IOL master. A prospective study publication-title: Bull Soc Belge Ophtalmol contributor: fullname: Verhulst E – ident: e_1_2_5_4_1 doi: 10.1093/brain/123.4.733 – ident: e_1_2_5_23_1 doi: 10.1136/jnnp.55.3.181 – ident: e_1_2_5_33_1 doi: 10.1093/brain/awp001 – ident: e_1_2_5_8_1 doi: 10.1002/mds.20308 – ident: e_1_2_5_32_1 doi: 10.1093/brain/awr225 – start-page: 728457 year: 2012 ident: e_1_2_5_11_1 article-title: Interocular asymmetry of foveal thickness in Parkinson's disease [serial online] publication-title: J Ophthalmol contributor: fullname: Schrier EM – ident: e_1_2_5_5_1 doi: 10.1007/s00415-005-0840-x – volume: 31 start-page: 2473 year: 1990 ident: e_1_2_5_12_1 article-title: Decreased dopamine in the retinas of patients with Parkinson's disease publication-title: Invest Ophthalmol Vis Sci contributor: fullname: Harnois C – ident: e_1_2_5_29_1 doi: 10.1038/eye.2008.363 – ident: e_1_2_5_31_1 doi: 10.1002/mds.22678 – ident: e_1_2_5_10_1 doi: 10.1002/cne.902100108 – ident: e_1_2_5_3_1 doi: 10.1212/WNL.0b013e31827deb74 – ident: e_1_2_5_24_1 doi: 10.1002/mds.21507 – ident: e_1_2_5_28_1 doi: 10.1016/j.ajo.2008.06.010 |
SSID | ssj0011516 |
Score | 2.476748 |
Snippet | ABSTRACT
Defective visual information processing from both central and peripheral pathways is one of the suggested mechanisms of visual hallucination in... Defective visual information processing from both central and peripheral pathways is one of the suggested mechanisms of visual hallucination in Parkinson's... |
SourceID | proquest crossref pubmed wiley istex |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 61 |
SubjectTerms | Aged Case-Control Studies Female Hallucinations - complications Hallucinations - pathology Hallucinations - psychology Humans Male Middle Aged Movement disorders optical computed tomography Parkinson Disease - complications Parkinson Disease - pathology Parkinson Disease - psychology Parkinson's disease retina thickness Retinal Neurons - pathology Tomography, Optical Coherence visual hallucination |
Title | Retinal nerve fiber layer thickness and visual hallucinations in Parkinson's Disease |
URI | https://api.istex.fr/ark:/67375/WNG-2W06882P-X/fulltext.pdf https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fmds.25543 https://www.ncbi.nlm.nih.gov/pubmed/23775932 https://www.proquest.com/docview/1491097340/abstract/ https://search.proquest.com/docview/1492701118 |
Volume | 29 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9UwFD-MCcMXP-ZXdRtRRH3pXW-SJi17kn0ibMjc2H0QQtOkMKad2FuR_fU7J7mtTBzI3go9oWlyTvI7yTm_A_DWcemIVCWtikynUtY8tbYp06LRXHhVUHImRVscqYNT-WmWz5Zga8iFifwQ44EbWUZYr8nAK9tt_iEN_e66CeJhSUyfRKRHgOh4pI5CoBPKnqIR5SFDeGAVyvjm2PLGXnSPhvX3v4DmTdwaNp69h_B16HKMN7mY9HM7qa_-YnO84z89ggcLQMo-Rg16DEu-XYWVw8WV-xM4OaakaJRoKTaSNRRhwr5ViNQZhcpf0FLJqtaxX-ddj2JUnKXHpvEkkJ23jBKrQ47Z-47txPugp3C6t3uyfZAuSjGktcy1SBuJyEwjdnKV8l6KGt2yosxUzZV1Fj1aO23KxutA35bVVmkhbTkt6wYdRsR04hkst5etfwHMOl-UKhdeqApVQ5XSa8QRzuW2qJqCJ_BmmBTzIzJumMitzA2Ojwnjk8C7MF2jBP4Jhajp3Jwd7Rt-RrV0-GczS2BtmE-zsM4O3Z2SLt6FzBJ4Pb5Gu6LLkqr1l32Q4RrVaFok8DzqwfgxLrTOEfgm8CHM5u39NIc7X8LDy_8XfQX3EZXJeM6zBsvzn71fR-QztxtBxa8B4mv7Ug |
link.rule.ids | 315,786,790,1382,27957,27958,46329,46753 |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3di9QwEB_OO1Bf_P6onhpF1JfudZM0acEX8TxXvV3k3OP2RULTpHCc9sTdivjXO5NsKycK4luhE5omM8lvMjO_ADx2XDoiVUmrItOplDVPrW3KtGg0F14VVJxJ2RYzNTmUbxf5YgOe97UwkR9iOHAjywjrNRk4HUjv_GIN_eyWIwTEUpyDLTT3PDhUBwN5FEKdcPEpmlEeaoR7XqGM7wxNz-xGWzSw3_8ENc8i17D17F2Gj32nY8bJyahb2VH94zc-x__9qytwaY1J2YuoRFdhw7fX4Px0HXW_DvMDqotGiZbSI1lDSSbsU4VgnVG2_AmtlqxqHft2vOxQjO5n6bBpPAxkxy2j2upQZvZ0yXZjSOgGHO69mr-cpOvbGNJa5lqkjURwphE-uUp5L0WNnllRZqrmyjqLTq0dN2XjdWBwy2qrtJC2HJd1gz4jwjpxEzbb09bfBmadL0qVCy9UhdqhSuk1QgnncltUTcETeNTPivkSSTdMpFfmBsfHhPFJ4EmYr0EC_4Sy1HRujmavDT-i63T4e7NIYLufULM20CV6PCXF3oXMEng4vEbTonhJ1frTLshwjXo0LhK4FRVh-BgXWueIfRN4Fqbz7_00090P4eHOv4s-gAuT-XTf7L-ZvbsLFxGkyXjssw2bq6-dv4dAaGXvB33_Ca1Y_3Q |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VVqq48H4EChiEgEu2WduxE3FCLEt5dFWVVt1DJSuObakqpBW7QYhfz4yzCSoCCXGLlLHi2DP2N_bMNwBPHZeOSFXSqsh0KmXNU2tDmRZBc-FVQcmZFG0xUzuH8v08n6_Byz4XpuOHGA7cyDLiek0Gfu7C9i_S0C9uMUI8LMUl2JBKcFLpyf7AHYVIJ9Y9RSvKY4pwTyuU8e2h6YXNaIPG9fufkOZF4Bp3nulVOO773AWcnI7apR3VP36jc_zPn7oGV1aIlL3qVOg6rPnmBmzuru7cb8LBPmVFo0RDwZEsUIgJ-1whVGcUK39KayWrGse-nSxaFKPqLC027Y4C2UnDKLM6Jpk9X7BJdyF0Cw6nbw5e76SrWgxpLXMt0iARmmkET65S3ktRo19WlJmqubLOoktrx6EMXkf-tqy2Sgtpy3FZB_QYEdSJ27DenDX-LjDrfFGqXHihKtQNVUqvEUg4l9uiCgVP4Ek_Kea8o9wwHbkyNzg-Jo5PAs_idA0S-CcUo6ZzczR7a_gRFdPhe2aewFY_n2Zlngv0d0q6eRcyS-Dx8BoNi25LqsaftVGGa1SjcZHAnU4Pho9xoXWOyDeBF3E2_95Pszv5FB_u_bvoI9jcm0zNx3ezD_fhMiI02Z35bMH68mvrHyAKWtqHUdt_Aq2r_iM |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Retinal+nerve+fiber+layer+thickness+and+visual+hallucinations+in+Parkinson%27s+Disease&rft.jtitle=Movement+disorders&rft.au=Lee%2C+Jee%E2%80%90Young&rft.au=Kim%2C+Jae+Min&rft.au=Ahn%2C+Jeeyun&rft.au=Kim%2C+Han%E2%80%90Joon&rft.date=2014-01-01&rft.issn=0885-3185&rft.eissn=1531-8257&rft.volume=29&rft.issue=1&rft.spage=61&rft.epage=67&rft_id=info:doi/10.1002%2Fmds.25543&rft.externalDBID=10.1002%252Fmds.25543&rft.externalDocID=MDS25543 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0885-3185&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0885-3185&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0885-3185&client=summon |